![](http://www.biohealthcapital.com/wp-content/uploads/2019/03/emergent-biosolution-logo_74d59ff341be395b9c5bb5a9f09c6e74.png)
Emergent BioSolutions announced today that the company has signed a deal with the U.S. Department of State to establish a supply chain for certain medical countermeasures that address chemical warfare agents.
Emergent BioSolutions announced today that the company has signed a deal with the U.S. Department of State to establish a supply chain for certain medical countermeasures that address chemical warfare agents.